“His inspiring presence will motivate us to scale greater heights in our quest to bridge unmet healthcare needs,” Zydus Cadila said in a regulatory filing.
The Zydus family comprising 25,000 Zydans stands committed to the ‘Aatmanirbhar Bharat‘ mission and offering the nation safe and efficacious vaccines, therapeutics and diagnostics to fight COVID-19, it added.
Zydus Cadila had earlier announced that the phase-I clinical trial of its vaccine candidate ZyCoV-D is over and it commenced phase-II clinical trials from August.